I'm sure it's been discussed somewhere on PR
I'm sure that part of the problem that the SEID rebranding won't resolve by itself is the amount of papers the psychobabblers have published pushing their CBT and GET and the influence they have over the wider medical community. Unfortunately until those papers are withdrawn
then it's going to continue to create a confusing environment for a doctor or researcher to learn about the disease and for patients to be helped.
The problem is the psychobabblers influence extends to government, insurance agencies and medical research funds. Until we really start to get more rituximab studies out and hopefully find a biomarker or something than I feel like the SEID name isn't going to do much good on its own.
A name is nothing if we don't have the science, the diagnostic tests and validated double-blind RCT treatments to go with it or at least a drug that reduces the symptoms. If we got approval for ampligen that would be a great step in the right direction because at least if your diagnosed there is a drug you could ask your doctor to give you. It would give patients power to get a treatment that might change their lives. At the moment we're stuck in a limbo.